What’s different about brain cancer?
Florey Prof Lucy Palmer says brain cancer differs from other cancers because the more electrical activity happening in the brain, the more cancer grows.
Read time: 2 mins
View more
Florey Prof Lucy Palmer says brain cancer differs from other cancers because the more electrical activity happening in the brain, the more cancer grows.
Read time: 2 mins
View more
Florey researcher Dr Leigh Walker has received CASS Foundation funding to address a major gap in neuroscience, examining sex differences in alcohol use.
Read time: 1 min
View more
Florey researchers have examined a so-called “miracle cure” for stroke and found it was more effective than an inactive placebo.
Read time: 3 mins
View more
Our researchers work to bridge the gap between research and patient care for those living with chronic mental health conditions.
View more
Our research in stroke, critical illness and cardiovascular, renal, gastrointestinal and metabolic diseases aims to transform patient care and outcomes.
View more
The Dementia Research Priority builds upon The Florey's world-leading dementia research to identify and trial new treatments and advance patient care.
View more
At the Florey our research focuses on how the healthy brain operates and what goes wrong to cause epilepsy, neurodevelopmental disorders and brain cancer.
View more
Researchers in the Neurodegeneration and Immunology Research Priority are working to improve care and develop new treatments for neurodegenerative diseases.
View more
Multiple sclerosis (MS) is characterised by sporadic autoimmune attacks on myelin, the lipid-dense sheath that encases neuronal axons. To date, no drugs that have been identified in mouse models of MS to promote repair and regeneration of this myelin sheath have translated through to clinical use. This highlights the need for improved model systems for biological interrogation into these processes, as…
Learn more